COURTNEY ELAM: Open Payments
NPI 1538501382 · OWINGSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$750 in 33 payments from 10 companies in 2025. Trend: 2023 $577 · 2024 $785 · 2025 $750
Food & beverage: $750
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $225 |
| Alkermes, Inc. | 5 | $217 |
| Vanda Pharmaceuticals Inc. | 5 | $83 |
| Axsome Therapeutics, Inc. | 4 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Lundbeck LLC | 1 | $20 |
| Corium, LLC | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: VRAYLAR, LYBALVI, ARISTADA, Auvelity, HETLIOZ, REXULTI, CAPLYTA, SPRAVATO.
Industry payments across KY — which companies pay providers there.
